IDEXX Laboratories, Inc. Stock Borsa Italiana
Stocks
1IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Borsa Italiana
2026-10-02
|
5-day change | 1st Jan Change | ||
| 463.10 EUR | +0.06% |
|
+1.96% | -20.32% |
| 09-30 | IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI | MT |
| 09-17 | Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike | MT |
| Market Cap | 40.84B 36.29B 33.87B 30.87B 58.22B 3,926B 58.76B 410B 159B 2,007B 153B 150B 6,441B | P/E 2026 * |
35.1x | P/E 2027 * | 31x |
|---|---|---|---|---|---|
| Enterprise Value | 41.21B 36.61B 34.17B 31.15B 58.74B 3,961B 59.29B 414B 160B 2,025B 155B 151B 6,499B | EV / Sales 2026 * |
8.73x | EV / Sales 2027 * | 7.93x |
| Free-Float |
72.37% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IDXX | Delayed | |
CBOE
| IDXX | Real-time | |
|
London S.E.
| 0J8P | Delayed | |
|
Tradegate
| IX1 | Real-time | |
|
Boerse Muenchen
| IX1 | Real-time | |
|
Mexican S.E.
| IDXX * | End-of-day quote | |
|
Deutsche Boerse AG
| IX1 | Delayed | |
|
Wiener Boerse
| IDXX | End-of-day quote | |
|
Börse Stuttgart
| IX1 | Delayed | |
|
Xetra
| IX1 | Delayed | |
|
Berne S.E.
| IX1 | End-of-day quote | |
|
Borsa Italiana
| 1IDXX | End-of-day quote |
Last Transcript: IDEXX Laboratories, Inc.
| 1 day | +0.06% | ||
| 1 week | +1.96% | ||
| Current month | +0.26% | ||
| 1 month | -2.26% | ||
| 3 months | -3.78% | ||
| 6 months | -5.39% | ||
| Current year | -20.32% |
| 1 week | 457.4 |  | 478.7 |
| 1 month | 382.7 | | 478.7 |
| Current year | 382.7 | | 629 |
| 1 year | 382.7 | | 664.6 |
| 3 years | 381.3 | | 664.6 |
| 5 years | 381.3 | | 664.6 |
| 10 years | 161.6 | | 664.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Erickson
CEO | Chief Executive Officer | 52 | 2026-05-11 |
Andrew Emerson
DFI | Director of Finance/CFO | 43 | 2025-02-28 |
Martin Smith
COO | Chief Operating Officer | 58 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 2026-05-11 | |
| Director/Board Member | 64 | 2013-07-14 | |
Daniel Junius
BRD | Director/Board Member | 73 | 2014-03-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +1.96% | - | - | 40.79B | |
| +0.84% | -3.74% | -26.69% | +1.85% | 167B | |
| -0.07% | -2.55% | -9.53% | +11.07% | 111B | |
| +0.90% | +1.13% | -24.83% | +0.58% | 105B | |
| -1.24% | -0.76% | -49.04% | -12.75% | 74.82B | |
| -0.24% | +0.69% | +0.16% | +72.58% | 59.11B | |
| -0.86% | +2.96% | +13.57% | +59.50% | 51.8B | |
| -0.71% | -3.82% | -7.72% | -31.41% | 48.5B | |
| +0.12% | -0.17% | -18.21% | +20.29% | 40.79B | |
| -1.01% | -1.45% | +28.48% | -9.72% | 32.54B | |
| Average | -0.22% | -0.59% | -10.42% | +12.44% | 76.68B | |
| Weighted average by Cap. | +0.02% | -1.11% | -16.32% | +10.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.72B 4.2B 3.92B 3.57B 6.73B 454B 6.79B 47.39B 18.37B 232B 17.73B 17.35B 745B | 5.14B 4.57B 4.26B 3.89B 7.33B 494B 7.4B 51.59B 19.99B 253B 19.3B 18.88B 811B |
| Net income | 1.18B 1.05B 978M 891M 1.68B 113B 1.7B 11.83B 4.58B 57.94B 4.43B 4.33B 186B | 1.31B 1.17B 1.09B 994M 1.87B 126B 1.89B 13.19B 5.11B 64.61B 4.94B 4.83B 207B |
| Net Debt | 368M 327M 305M 278M 525M 35.38B 529M 3.69B 1.43B 18.08B 1.38B 1.35B 58.04B | -97.34M -86.49M -80.72M -73.57M -139M -9.36B -140M -977M -379M -4.78B -365M -358M -15.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | €463.10 | +0.06% | 0 |
| 26-10-01 | €462.80 | +0.19% | 5 |
| 26-09-30 | €461.90 | -0.84% | 0 |
| 26-09-29 | €465.80 | +1.84% | 0 |
| 26-09-28 | €457.40 | +0.70% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IDXX Stock
- 1IDXX Stock
Select your edition
All financial news and data tailored to specific country editions
